Clinical Trial Update: The Impact of Udenafil on Exercise Capacity in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating udenafil on exercise capacity in patients with severe COPD (including those with COPD-associated pulmonary hypertension) has been compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pulmonary Hypertension

Drugs mentioned

• udenafil (udenafil)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Dyspnea, Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED